ICPT - INTERCEPT PHARMACEUTICALS, INC.
IEX Last Trade
10.65
0.260 2.441%
Share volume: 789,330
Last Updated: Tue 08 Aug 2023 09:59:59 PM CEST
Pharmaceutical Preparation Manufacturing :
2.70%
PREVIOUS CLOSE
CHG
CHG%
$10.39
0.26
2.50%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-06 | 2022-08-03 | 2022-11-01 | 2023-03-02 | 2023-04-27 | 2023-08-02 | |
| Total revenue | 88.582 M | 71.757 M | 77.588 M | 47.783 M | 67.958 M | 83.718 M | |
| Cost of revenue | 758.000 K | 309.000 K | 424.000 K | -507.000 K | 222.000 K | 185.000 K | |
| Gross profit | 87.824 M | 71.448 M | 77.164 M | 48.290 M | 67.736 M | 83.533 M | |
| -18.65% | 8.00% | -37.42% | 40.27% | 23.32% | |||
| Operating expenses | 98.096 M | 84.811 M | 87.308 M | 82.727 M | 99.368 M | 90.652 M | |
| Selling general and admin | 50.007 M | 39.985 M | 43.274 M | 43.037 M | 57.657 M | 53.346 M | |
| Research and development | 48.089 M | 44.826 M | 44.034 M | 39.690 M | 41.711 M | 37.306 M | |
| Total expenses | 98.854 M | 85.120 M | 87.732 M | 82.220 M | 99.590 M | 90.837 M | |
| -13.89% | 3.07% | -6.28% | 21.13% | -8.79% | |||
| Operating income | -10.272 M | -13.363 M | -10.144 M | -34.437 M | -31.632 M | -7.119 M | |
| Ebit | -10.272 M | -13.363 M | -10.144 M | -34.437 M | -31.632 M | -7.119 M | |
| Pretax income | -17.284 M | -20.321 M | -104.087 M | -33.166 M | -31.881 M | -5.826 M | |
| 17.57% | 412.21% | -68.14% | -3.87% | -81.73% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -17.284 M | -7.528 M | 267.453 M | -20.825 M | -32.135 M | -5.862 M | |
| 56.45% | 3,652.78% | -107.79% | -54.31% | 81.76% | |||
| Net income | -17.284 M | -7.528 M | 267.453 M | -20.825 M | -32.135 M | -5.862 M | |
| 56.45% | 3,652.78% | -107.79% | -54.31% | 81.76% |